Vaccines, therapeutics, and diagnostics for covid-19 : redesigning systems to improve pandemic response
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:375 |
|---|---|
| Enthalten in: |
BMJ (Clinical research ed.) - 375(2021) vom: 28. Nov., Seite e067488 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ramchandani, Rohit [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
5CSZ8459RP |
|---|
| Anmerkungen: |
Date Completed 08.12.2021 Date Revised 14.12.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmj-2021-067488 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333772377 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333772377 | ||
| 003 | DE-627 | ||
| 005 | 20231225222333.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmj-2021-067488 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1112.xml |
| 035 | |a (DE-627)NLM333772377 | ||
| 035 | |a (NLM)34840135 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ramchandani, Rohit |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vaccines, therapeutics, and diagnostics for covid-19 |b redesigning systems to improve pandemic response |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.12.2021 | ||
| 500 | |a Date Revised 14.12.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Hydroxylamines |2 NLM | |
| 650 | 7 | |a Cytidine |2 NLM | |
| 650 | 7 | |a 5CSZ8459RP |2 NLM | |
| 650 | 7 | |a molnupiravir |2 NLM | |
| 650 | 7 | |a YA84KI1VEW |2 NLM | |
| 700 | 1 | |a Kazatchkine, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Joanne |e verfasserin |4 aut | |
| 700 | 1 | |a Sudan, Preeti |e verfasserin |4 aut | |
| 700 | 1 | |a Dybul, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Matsoso, Precious |e verfasserin |4 aut | |
| 700 | 1 | |a Nordström, Anders |e verfasserin |4 aut | |
| 700 | 1 | |a Phelan, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Legido-Quigley, Helena |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Sudhvir |e verfasserin |4 aut | |
| 700 | 1 | |a Mabuchi, Shunsuke |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ (Clinical research ed.) |d 1988 |g 375(2021) vom: 28. Nov., Seite e067488 |w (DE-627)NLM012612685 |x 1756-1833 |7 nnns |
| 773 | 1 | 8 | |g volume:375 |g year:2021 |g day:28 |g month:11 |g pages:e067488 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmj-2021-067488 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 375 |j 2021 |b 28 |c 11 |h e067488 | ||